Advanced Filters
noise

Human Papilloma Virus Clinical Trials

A listing of Human Papilloma Virus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 280 clinical trials
Y Yanxia Yu

A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects

This is a single-centre, randomised, open-label, single-dose, two-cycle, double-crossover study to compare the pharmacokinetics of SJ04 and Ovidrel® in healthy female subjects. Received a single subcutaneous injection administration of SJ04 Injection or Ovidrel®, both administered at a dose of 250 μg, once per cycle, and cross-administered after a washout period.

20 - 40 years of age Female Phase 1
E ELENA LABARTA, MD

Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters

After so many years conducting artificial endometrial preparation cycles for embryo transfer, there is no clear indication about which is the optimal dose of exogenous progesterone in this scenario to optimize the outcome. Taking into account that the luteal phase can be controlled by measuring serum P levels (not done …

18 - 35 years of age Female Phase 4
K Katherine Kuhn

Convergent Mechanisms Underlying Reprometabolic Syndrome in Women

Dr. Nanette Santoro proposes to test the specific question that obesity results in abnormal estradiol response at the level of the pituitary and hypothalamus. This will be shown in diminished pituitary sensitivity to gonadorelin releasing hormone with a reduced estradiol induced luteinizing hormone surge in obese women.

18 - 38 years of age Female Phase 2
A Agni Pantou, M.D

Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders

Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.

35 - 47 years of age Female Phase 2/3
J Jiri Fronek, Assoc Prof

Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study

Uterus transplantation (UTx) is the only causative treatment for congenital or acquired uterus absence. Individual cases of UTx from a live donor (LD UTx) with healthy child birth performed so far showed favourable outcomes. The present study will include both LD UTx and UTx from deceased donors after brain death …

18 - 60 years of age Female Phase 3
A Agni Pantou, M.D

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.

45 - 55 years of age Female Phase 2/3
D Diego Raimondo, MD

Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma

The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.

years of age Female Phase N/A
H Hadas Lemberg, PhD

Inflammation Markers in Fluid Aspirate From a Scarred Uterine vs. a Normal Uterine Cavity

A prospective study that will take place in the hydrosonography clinic, comparing patients with an intact uterus to those who had a caesarean section. Eligible patients will preform a transvaginal ultrasound for evaluation of presence of a niche. After fixation of the transcervical catheter, we will flush 2 ml sterile …

18 - 40 years of age Female Phase N/A
U Ulla B Knudsen, Professor

Impact of Operation on Fertility for Women With Severe Endometriosis

The EFFORT study compares the impact on fertility of operation or fertility treatment (IVF, in vitro fertilization) in a multicenter randomized controlled trial. The study population consists of women with colorectal deep infiltrating endometriosis and a pregnancy intention. These women will be randomized to either of the two treatment groups: …

18 - 38 years of age Female Phase N/A
J Jonalyn Edades

Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support

To evaluate whether single euploid embryo transfer in NC without routinely administered LPS is non-inferior to NC with routinely administered LPS.

18 - 40 years of age Female Phase 1

Simplify language using AI